Foghorn Therapeutics Inc (FHTX)
7.84
+0.12
(+1.55%)
USD |
NASDAQ |
Nov 22, 16:00
7.84
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Total Assets (Quarterly): 308.37M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 308.37M |
| June 30, 2024 | 328.58M |
| March 31, 2024 | 255.00M |
| December 31, 2023 | 285.92M |
| September 30, 2023 | 313.42M |
| June 30, 2023 | 339.58M |
| March 31, 2023 | 372.88M |
| December 31, 2022 | 404.88M |
| September 30, 2022 | 433.93M |
| June 30, 2022 | 456.90M |
| Date | Value |
|---|---|
| March 31, 2022 | 488.30M |
| December 31, 2021 | 519.77M |
| September 30, 2021 | 186.07M |
| June 30, 2021 | 208.53M |
| March 31, 2021 | 229.89M |
| December 31, 2020 | 255.59M |
| September 30, 2020 | 142.43M |
| June 30, 2020 | 94.31M |
| December 31, 2019 | 22.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.34M
Minimum
Dec 2019
519.77M
Maximum
Dec 2021
297.20M
Average
308.37M
Median
Sep 2024
Total Assets (Quarterly) Benchmarks
| Sana Biotechnology Inc | 559.39M |
| Omega Therapeutics Inc | 152.73M |
| Moderna Inc | 15.80B |
| United Therapeutics Corp | 7.123B |
| CEL-SCI Corp | 24.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 336.66M |
| Shareholders Equity (Quarterly) | -28.29M |
| Current Ratio | 4.773 |